Novartis and Genentech jointly research new medicine, not approved to sell

Swiss pharmaceutical factory Novartis and American pharmaceutical factory Genentech has jointly worked out a new kind of medicine Xolair, which cures allergy and asthma, but it has not been approved by the relevant US authority

Related stock : (NIL)